Home › NDC Lookup › RxCUI directory › RxCUI 427163

Nitazoxanide 500 MG Oral Tablet — RxCUI 427163

Name: Nitazoxanide 500 MG Oral Tablet (RxCUI 427163)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 427163 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI427163

Official nameNitazoxanide 500 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped4

Package NDCs mapped9

Reported Medicaid activity (SDUD)378 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nitazoxanide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It treats diarrhea caused by two specific intestinal parasites — Giardia lamblia and Cryptosporidium parvum. It's not a general antibiotic for all kinds of diarrhea. If your diarrh...
Yes, taking it with food is genuinely important — not just a suggestion. Food significantly increases how much of the active drug your body actually absorbs, which is what makes it...
Do I really have to take this with food? What if I forget?
That's actually a known and documented side effect called chromaturia — urine discoloration. It's been seen in clinical trials and is generally not dangerous. It should go away whe...

📖 Read our full Nitazoxanide guide →

🕸️ Concept Web — How Nitazoxanide 500 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Nitazoxanide 500 MG Oral Tablet RxCUI 427163 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Nitazoxanide 31819 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Alinia 352403 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Nitazoxanide Oral Tablet 446753 SCDF
- Nitazoxanide Oral Product 1158958 SCDG
- Nitazoxanide Pill 1158959 SCDG
- Nitazoxanide Oral Tablet [Alinia] 540616 SBDF
- Alinia Oral Product 1175528 SBDG
- Alinia Pill 1175529 SBDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Nitazoxanide 500 MG 446755 SCDC
- Nitazoxanide 500 MG Oral Tablet [Alinia] 540617 SBD
- Nitazoxanide 500 MG [Alinia] 540615 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Nitazoxanide 500 MG SCDC · 446755
Nitazoxanide Oral Tablet SCDF · 446753
Nitazoxanide Oral Product SCDG · 1158958
Nitazoxanide Pill SCDG · 1158959

Brand-Name Concepts

Nitazoxanide 500 MG Oral Tablet [Alinia] SBD · 540617
Nitazoxanide 500 MG [Alinia] SBDC · 540615
Nitazoxanide Oral Tablet [Alinia] SBDF · 540616
Alinia Oral Product SBDG · 1175528
Alinia Pill SBDG · 1175529
Alinia BN · 352403

📦 FDA Products & Package NDCs

4 products · 9 package NDCs

9 package NDCs map to RxCUI 427163 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
13517-0135-06	6 TABLET in 1 BOTTLE (13517-135-06)	Nitazoxanide	e5 Pharma, LLC	2026-06-01
31722-0100-30	1 BOTTLE in 1 CARTON (31722-100-30) / 30 TABLET, FILM COATE...	Nitazoxanide	Camber Pharmaceuticals, Inc.	2025-04-15
31722-0100-31	1 BOTTLE in 1 CARTON (31722-100-31) / 12 TABLET, FILM COATE...	Nitazoxanide	Camber Pharmaceuticals, Inc.	2025-04-15
31722-0100-32	1 BOTTLE in 1 CARTON (31722-100-32) / 6 TABLET, FILM COATED...	Nitazoxanide	Camber Pharmaceuticals, Inc.	2025-04-15
64980-0526-03	30 TABLET, FILM COATED in 1 BOTTLE (64980-526-03)	Nitazoxanide	Rising Pharma Holdings, Inc.	2020-11-27
64980-0526-21	12 TABLET, FILM COATED in 1 BOTTLE (64980-526-21)	Nitazoxanide	Rising Pharma Holdings, Inc.	2020-11-27
64980-0526-60	6 TABLET, FILM COATED in 1 BOTTLE (64980-526-60)	Nitazoxanide	Rising Pharma Holdings, Inc.	2020-11-27
64980-0526-81	18 TABLET, FILM COATED in 1 BOTTLE (64980-526-81)	Nitazoxanide	Rising Pharma Holdings, Inc.	2020-11-27
70954-0934-10	6 TABLET in 1 BOTTLE (70954-934-10)	Nitazoxanide	ANI Pharmaceuticals, Inc.	2025-03-05

Observed labelers: Rising Pharma Holdings, Inc. (4) · Camber Pharmaceuticals, Inc. (3) · ANI Pharmaceuticals, Inc. (1) · e5 Pharma, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.